1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

1,2-Distearoyl-sn-glycero-3-phosphoethanolamine is a lipid of Glycerophospholipids (GP) class. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine is associated with abnormalities such as Painful Bladder Syndrome, Dehydration, Renal tubular disorder, Gigantism and Tumor-Associated Vasculature. The involved functions are known as conjugation, Ligand Binding, Process, Laser-generated electromagnetic radiation and Blood Circulation. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine often locates in Tissue membrane, Early endosome, Body tissue, Cell surface and Membrane. The associated genes with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine are R peptide, P4HTM gene, NHS gene, TSPO gene and SLC33A1 gene. The related lipids are Liposomes, 1,2-distearoylphosphatidylethanolamine, Micelles, Fatty Acids and sialogangliosides.

Cross Reference

Introduction

To understand associated biological information of 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

1,2-Distearoyl-sn-glycero-3-phosphoethanolamine is suspected in Renal tubular disorder, Entrapment, Painful Bladder Syndrome, Dehydration, Gigantism, Tumor-Associated Vasculature and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Body Weight D001835 333 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Melanoma D008545 69 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Hepatoblastoma D018197 10 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Total 10

PubChem Associated disorders and diseases

What pathways are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

Download all related citations
Per page 10 20 50 100 | Total 255
Authors Title Published Journal PubMed Link
Maeda N et al. Synthesis of angiogenesis-targeted peptide and hydrophobized polyethylene glycol conjugate. 2004 Bioorg. Med. Chem. Lett. pmid:15013013
Hoarau D et al. Novel long-circulating lipid nanocapsules. 2004 Pharm. Res. pmid:15553223
Zhang Y et al. Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes. 2004 Anal. Biochem. pmid:15301962
Koo OM et al. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine. 2005 Nanomedicine pmid:17292061
Zhang J et al. Transbilayer complementarity of phospholipids in cholesterol-rich membranes. 2005 Biochemistry pmid:15736969
Shiokawa T et al. Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo. 2005 Clin. Cancer Res. pmid:15756028
Arleth L et al. Detailed structure of hairy mixed micelles formed by phosphatidylcholine and PEGylated phospholipids in aqueous media. 2005 Langmuir pmid:15807565
Garbuzenko O et al. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. 2005 Chem. Phys. Lipids pmid:15921973
Xiong XB et al. [Preparation of doxorubicin-loaded stealth liposomes modified with RGD mimetic and cellular association in vitro]. 2005 Yao Xue Xue Bao pmid:16496670
Cao H et al. A chemical sensor for the liquid-ordered phase. 2005 J. Am. Chem. Soc. pmid:15954788
Ishida T et al. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection. 2006 J Control Release pmid:17045355
Hashizaki K et al. Calorimetry and cryo-transmission electron microscopic studies of PEG2000-grafted liposomes. 2006 Chem. Pharm. Bull. pmid:16595966
Ickenstein LM et al. Effects of phospholipid hydrolysis on the aggregate structure in DPPC/DSPE-PEG2000 liposome preparations after gel to liquid crystalline phase transition. 2006 Biochim. Biophys. Acta pmid:16574061
Ishida T et al. Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes. 2006 J Control Release pmid:17011060
Nallamothu R et al. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies. 2006 May-Jun PDA J Pharm Sci Technol pmid:17089683
Dos Santos N et al. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. 2007 Biochim. Biophys. Acta pmid:17400180
Calvagno MG et al. Effects of lipid composition and preparation conditions on physical-chemical properties, technological parameters and in vitro biological activity of gemcitabine-loaded liposomes. 2007 Curr Drug Deliv pmid:17269921
Terada T et al. Optimization of tumor-selective targeting by basic fibroblast growth factor-binding peptide grafted PEGylated liposomes. 2007 J Control Release pmid:17467100
Vandenbroucke RE et al. Cellular entry pathway and gene transfer capacity of TAT-modified lipoplexes. 2007 Biochim. Biophys. Acta pmid:17188643
Romberg B et al. Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration. 2007 Biochim. Biophys. Acta pmid:17223070